341 related articles for article (PubMed ID: 25846820)
1. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
[TBL] [Abstract][Full Text] [Related]
2. The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth.
Wilson SM; Moutal A; Melemedjian OK; Wang Y; Ju W; François-Moutal L; Khanna M; Khanna R
Front Cell Neurosci; 2014; 8():196. PubMed ID: 25104922
[TBL] [Abstract][Full Text] [Related]
3. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.
Moutal A; Chew LA; Yang X; Wang Y; Yeon SK; Telemi E; Meroueh S; Park KD; Shrinivasan R; Gilbraith KB; Qu C; Xie JY; Patwardhan A; Vanderah TW; Khanna M; Porreca F; Khanna R
Pain; 2016 Jul; 157(7):1448-1463. PubMed ID: 26967696
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
[TBL] [Abstract][Full Text] [Related]
5. Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization.
Wilson SM; Xiong W; Wang Y; Ping X; Head JD; Brittain JM; Gagare PD; Ramachandran PV; Jin X; Khanna R
Neuroscience; 2012 May; 210():451-66. PubMed ID: 22433297
[TBL] [Abstract][Full Text] [Related]
6. Regulation of CRMP2 by Cdk5 and GSK-3β participates in sevoflurane-induced dendritic development abnormalities and cognitive dysfunction in developing rats.
Liao Z; Huang Z; Li J; Li H; Miao L; Liu Y; Zhang J; Xu Y; Li Y
Toxicol Lett; 2021 May; 341():68-79. PubMed ID: 33548343
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.
Yu J; Moutal A; Dorame A; Bellampalli SS; Chefdeville A; Kanazawa I; Pham NYN; Park KD; Weimer JM; Khanna R
Mol Neurobiol; 2019 Jul; 56(7):5241-5255. PubMed ID: 30565051
[TBL] [Abstract][Full Text] [Related]
8. Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2.
Brittain JM; Wang Y; Eruvwetere O; Khanna R
FEBS Lett; 2012 Nov; 586(21):3813-8. PubMed ID: 23022559
[TBL] [Abstract][Full Text] [Related]
9. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
[TBL] [Abstract][Full Text] [Related]
10. Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamide.
Wilson SM; Khanna R
Mol Neurobiol; 2015 Apr; 51(2):599-609. PubMed ID: 24944082
[TBL] [Abstract][Full Text] [Related]
11. Proteome and behavioral alterations in phosphorylation-deficient mutant Collapsin Response Mediator Protein2 knock-in mice.
Nakamura H; Takahashi-Jitsuki A; Makihara H; Asano T; Kimura Y; Nakabayashi J; Yamashita N; Kawamoto Y; Nakamura F; Ohshima T; Hirano H; Tanaka F; Goshima Y
Neurochem Int; 2018 Oct; 119():207-217. PubMed ID: 29758318
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of Cdk5-phosphorylated CRMP2 following a spared nerve injury.
Moutal A; Ji Y; Bellampalli SS; Khanna R
Mol Brain; 2020 Jun; 13(1):97. PubMed ID: 32571373
[TBL] [Abstract][Full Text] [Related]
13. Lacosamide modulates collapsin response mediator protein 2 and inhibits mossy fiber sprouting after kainic acid-induced status epilepticus.
Wang X; Yu Y; Ma R; Shao N; Meng H
Neuroreport; 2018 Nov; 29(16):1384-1390. PubMed ID: 30169428
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of CRMP2 by Cdk5 Regulates Dendritic Spine Development of Cortical Neuron in the Mouse Hippocampus.
Jin X; Sasamoto K; Nagai J; Yamazaki Y; Saito K; Goshima Y; Inoue T; Ohshima T
Neural Plast; 2016; 2016():6790743. PubMed ID: 26819770
[TBL] [Abstract][Full Text] [Related]
15. Dynamic CRMP2 Regulation of CaV2.2 in the Prefrontal Cortex Contributes to the Reinstatement of Cocaine Seeking.
Buchta WC; Moutal A; Hines B; Garcia-Keller C; Smith ACW; Kalivas P; Khanna R; Riegel AC
Mol Neurobiol; 2020 Jan; 57(1):346-357. PubMed ID: 31359322
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of (
Moutal A; Eyde N; Telemi E; Park KD; Xie JY; Dodick DW; Porreca F; Khanna R
Pain Rep; 2016 Jun; 1(1):. PubMed ID: 27917413
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase 5/Collapsin response mediator protein 2 pathway may mediate sevoflurane-induced dendritic development abnormalities in rat cortical neurons.
Liu Y; Lin D; Liu C; Zhao Y; Shen Z; Zhang K; Cao M; Li Y
Neurosci Lett; 2017 Jun; 651():21-29. PubMed ID: 28445771
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
Isono T; Yamashita N; Obara M; Araki T; Nakamura F; Kamiya Y; Alkam T; Nitta A; Nabeshima T; Mikoshiba K; Ohshima T; Goshima Y
Neurosci Res; 2013 Nov; 77(3):180-5. PubMed ID: 23994236
[TBL] [Abstract][Full Text] [Related]
19. Collapsin response-mediator protein 5 (CRMP5) phosphorylation at threonine 516 regulates neurite outgrowth inhibition.
Brot S; Smaoune H; Youssef-Issa M; Malleval C; Benetollo C; Besançon R; Auger C; Moradi-Améli M; Honnorat J
Eur J Neurosci; 2014 Oct; 40(7):3010-20. PubMed ID: 25040932
[TBL] [Abstract][Full Text] [Related]
20. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression.
Cole AR; Noble W; van Aalten L; Plattner F; Meimaridou R; Hogan D; Taylor M; LaFrancois J; Gunn-Moore F; Verkhratsky A; Oddo S; LaFerla F; Giese KP; Dineley KT; Duff K; Richardson JC; Yan SD; Hanger DP; Allan SM; Sutherland C
J Neurochem; 2007 Nov; 103(3):1132-44. PubMed ID: 17683481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
